Evidence map›Paper›PMID 39223140›Full record

ArticleNature communications2024

DMDA-PatA mediates RNA sequence-selective translation repression by anchoring eIF4A and DDX3 to GNG motifs.

Hironori Saito, Yuma Handa, Mingming Chen, Tilman Schneider-Poetsch, Yuichi Shichino, Mari Takahashi, Daniel Romo, Minoru Yoshida, Alois Fürstner, Takuhiro Ito and 2 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hironori SaitoRNA Systems Biochemistry Laboratory, RIKEN Cluster for Pioneering Research, Wako, Saitama, Japan.
Yuma HandaSchool of Pharmacy and Pharmaceutical Sciences, Hoshi University, Shinagawa, Tokyo, Japan.
Mingming ChenRNA Systems Biochemistry Laboratory, RIKEN Cluster for Pioneering Research, Wako, Saitama, Japan.
Tilman Schneider-PoetschChemical Genomics Research Group, RIKEN Center for Sustainable Resource Science, Wako, Saitama, Japan.
Yuichi ShichinoRNA Systems Biochemistry Laboratory, RIKEN Cluster for Pioneering Research, Wako, Saitama, Japan.ORCID 0000-0002-0093-1185
Mari TakahashiLaboratory for Translation Structural Biology, RIKEN Center for Biosystems Dynamics Research, Tsurumi-ku, Yokohama, Japan.ORCID 0000-0002-9995-0019
Daniel RomoDepartment of Chemistry & Biochemistry and Baylor Synthesis and Drug-Lead Discovery Laboratory, Baylor University, Waco, TX, USA.ORCID 0000-0003-3805-092X
Minoru YoshidaChemical Genomics Research Group, RIKEN Center for Sustainable Resource Science, Wako, Saitama, Japan.ORCID 0000-0002-4376-5674
Alois FürstnerMax-Planck-Institut für Kohlenforschung, Mülheim/Ruhr, Germany.
Takuhiro ItoLaboratory for Translation Structural Biology, RIKEN Center for Biosystems Dynamics Research, Tsurumi-ku, Yokohama, Japan.ORCID 0000-0003-3704-5205
Kaori FukuzawaSchool of Pharmacy and Pharmaceutical Sciences, Hoshi University, Shinagawa, Tokyo, Japan.ORCID 0000-0001-5357-8250
Shintaro IwasakiRNA Systems Biochemistry Laboratory, RIKEN Cluster for Pioneering Research, Wako, Saitama, Japan. shintaro.iwasaki@riken.jp.ORCID 0000-0001-7724-3754

Funding

Synthetic/Mechanistic Studies of Bioactive Marine AgentsR37GM052964 · NIGMS · TEXAS A&M UNIVERSITY · PI ROMO, DANIEL · 2009 to 2019
$3.6M
SYNTHETIC/MECHANISTIC STUDIES OF BIOACTIVE MARINE AGENTSR01GM052964 · NIGMS · TEXAS A&M UNIVERSITY SYSTEM · PI ROMO, DANIEL · 2000 to 2008
$2.4M
Pacific Biosciences PacBio RS Single Molecule Real Time SequencerS10OD018174 · OD · UNIVERSITY OF CALIFORNIA BERKELEY · PI ROKHSAR, DANIEL SOLEYMAN · 2014 to 2014
$600k
STRUCTURAL/SYNTHETIC STUDIES OF BIOACTIVE MARINE AGENTSR29GM052964 · NIGMS · TEXAS A&M UNIVERSITY SYSTEM · PI ROMO, DANIEL · 1995 to 1999
–
Japan Agency for Medical Research and Development (AMED) JP23gm1410001MEXT | Japan Society for the Promotion of Science (JSPS) JP19H05640MEXT | Japan Society for the Promotion of Science (JSPS) JP23H00095MEXT | Japan Society for the Promotion of Science (JSPS) JP23H02415MEXT | Japan Society for the Promotion of Science (JSPS) JP23K05648MEXT | RIKEN Incentive Research ProjectsMEXT | RIKEN Pioneering ProjectsMinistry of Education, Culture, Sports, Science and Technology (MEXT) JP18H05503Ministry of Education, Culture, Sports, Science and Technology (MEXT) JP20H05784Ministry of Education, Culture, Sports, Science and Technology (MEXT) JP21H05281Ministry of Education, Culture, Sports, Science and Technology (MEXT) JP21H05734Ministry of Education, Culture, Sports, Science and Technology (MEXT) JP23H04268Ministry of Education, Culture, Sports, Science and Technology (MEXT) JP24H02307NIGMS NIH HHS R01 GM052964NIGMS NIH HHS R29 GM052964NIGMS NIH HHS R37 GM052964NIH HHS S10 OD018174
6 · The paper itself

Abstract

Small-molecule compounds that elicit mRNA-selective translation repression have attracted interest due to their potential for expansion of druggable space. However, only a limited number of examples have been reported to date. Here, we show that desmethyl desamino pateamine A (DMDA-PatA) represses translation in an mRNA-selective manner by clamping eIF4A, a DEAD-box RNA-binding protein, onto GNG motifs. By systematically comparing multiple eIF4A inhibitors by ribosome profiling, we found that DMDA-PatA has unique mRNA selectivity for translation repression. Unbiased Bind-n-Seq reveals that DMDA-PatA-targeted eIF4A exhibits a preference for GNG motifs in an ATP-independent manner. This unusual RNA binding sterically hinders scanning by 40S ribosomes. A combination of classical molecular dynamics simulations and quantum chemical calculations, and the subsequent development of an inactive DMDA-PatA derivative reveals that the positive charge of the tertiary amine on the trienyl arm induces G selectivity. Moreover, we identified that DDX3, another DEAD-box protein, is an alternative DMDA-PatA target with the same effects on eIF4A. Our results provide an example of the sequence-selective anchoring of RNA-binding proteins and the mRNA-selective inhibition of protein synthesis by small-molecule compounds.

Indexed as

DEAD-box RNA HelicasesEukaryotic Initiation Factor-4AProtein BiosynthesisRNA, MessengerEpoxy CompoundsHEK293 CellsHumansMacrolidesMolecular Dynamics SimulationNucleotide MotifsProtein BindingRibosomesThiazolesDDX3X protein, humanDEAD-box RNA HelicasesEIF4A1 protein, humanEpoxy CompoundsEukaryotic Initiation Factor-4AMacrolidespateamine ARNA, MessengerThiazoles

Identifiers

PMID39223140
PMCPMC11369270

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.